Safety data from 9 phase 3 UPA trials (RA, PsA & AS). In 11,271 pt-yrs exposure, no increased signal for cancer (excluding NMSC) cf. ADA/MTX. NMSC was higher however.
What data (if any) would reassure people in this space?
@RheumNow ABST0292 #ACR22
Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis - ACR Meeting Abstracts
What data (if any) would reassure people in this space?
@RheumNow ABST0292 #ACR22
